Strain Name: |
C.Cg-Tg(Ins2-CD80)3B7Flv/LwnJ |
|---|---|
Stock Number: |
005713 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Former Name |
C.Cg-Tg(Ins2-CD80)3B7Flv/FswJ (Changed: 07-MAR-06
) |
| Strain Common Names | BALB.RIP-B7.1; BALB.RIP-CD80; BALB.RIPB7; |
| Genes & Alleles | CD80; Ins2; Tg(Ins2-CD80)3B7Flv; |
Type JAX® GEMM® Strain - Congenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Transgenic Species laboratory mouse Background Strain BALB/c Donor Strain (C57BL/6 X CBA)F2 Donating Investigator Li Wen, Yale School of Medicine H2 Haplotype d Generation N10F5+F1N1p (05-FEB-06) Appearance
albino, pink eyed
Related Genotype: A/A Tyrc/TyrcStrain Description
Transgenic mice are characterized by pancreatic beta cells that express a rat insulin promoter (Ins2) regulated transgene encoding the human CD80 T cell co-stimulatory molecule. These mice are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. Approximately 10% of the BALB transgenic mice become diabetic by 30 weeks of age compared the control BALBs which are diabetes resistant. Spleens of diabetic BALB transgenic mice used in adoptive transfer experiments do not transfer diabetes to NOD.scid/RIP-B7.1.C.Cg-Tg(Ins2-CD80)3B7Flv/FswJ provides a tool for studying mechanisms for loss of tolerance in potentially diabetogenic CD8 T-cells.
Strain Development
A transgenic construct containing the human CD80 gene driven by the rat insulin promoter 1 (Rip) was injected fertilized eggs of a mating between C57BL/6 and CBA/Ca strains in the laboratory of Dr. Richard Flavell (Yale University). Founder animals were obtained and bred to C57BL/6 mice and subsequently mated to NOR/Lt or BALB/c for 10 generations and B6.Cg-H2g7 for 1 generation. In 2005, The Jackson Laboratory received this C.Cg-Tg(Ins2-CD80)3B7FLV/FswJ at N10F5.
Related Disease (OMIM) Terms |
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Tg(Ins2-CD80)3B7Flv | ||
|---|---|---|---|
| Allele Name | transgene insertion 3B7, Richard Flavell | ||
| Common Name(s) | RIP-B7; RIP-B7-1; RIP-B7.1; RIP-CD80; | ||
| Mutation Made By | Richard Flavell, Yale University School of Medicine | ||
| Strain of Origin | (C57BL/6 x CBA/Ca)F2 | ||
| Expressed Gene | CD80, CD80 molecule, human | ||
| Promoter | Ins2, insulin 2, rat | ||
| General Note | Mice carrying this transgene that also are homozygous for Prkdcscid are characterized by pancreatic beta cells that express a rat insulin II promoter regulated transgene encoding the human CD80 T cell co-stimulatory molecule. | ||
| Molecular Note | The transgene contains a human CD80 antigen gene driven by the rat insulin II promoter (Ins2). [MGI Ref ID J:88250] | ||
| Control | ||
|---|---|---|
| 000651 BALB/cJ | (approximate) | |
| Considerations for Choosing Controls | ||
Tg(Ins2-CD80)3B7Flv
Strains carrying Tg(Ins2-CD80)3B7Flv allele
005715 B6.Cg H2g7-Tg(Ins2-CD80)3B7Flv/LwnJ 004346 NOD.Cg-Prkdcscid Tg(Ins2-CD80)3B7Flv/DvsJ 005714 NOR.Cg-Tg(Ins2-CD80)3B7Flv/LwnJ View Strains carrying Tg(Ins2-CD80)3B7Flv (3 strains)
Strains carrying other alleles of Ins2
View Strains carrying other alleles of Ins2 (39 strains)
Congenic Nomenclature
Diabetes and Obesity Research
Type 1 Diabetes (IDDM) Analysis Strains (NOD Transgenics)
Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Research Tools
Diabetes and Obesity Research
Selected Reference(s)
Additional ReferencesWong FS; Du W; Thomas IJ; Wen L. 2005. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice. Diabetes 54(7):2032-40. [PubMed: 15983204] [MGI Ref ID J:109830]
| Strain Name: | C.Cg-Tg(Ins2-CD80)3B7Flv/LwnJ |
| Stock Number: | 005713 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form